Why a fundamental reimagining of how clinical studies operate is still necessary to achieve a true paradigm shift—and shed the cycle of reliance on incremental gains.

In this video interview, Heather Horville, solutions consultant at Greenphire, emphasizes the growing need for clinical ...

Patients deserve to benefit from the power of their data, but they also deserve to know, to choose, and to trust.

Some of the most interesting data are precisely those illustrating the reality of clinical practice of physicians attending ...

Wellsheet, a leader in AI clinical workflows and operations, today announced a new Care Team Copilot that combines chart summarization, multidisciplinary rounding and discharge, and AI-generated ...

Willebrand disease (VWD) is considered the most common inherited bleeding disorder, even surpassing haemophilia A. Nevertheless, ...

Background Restarting direct oral anticoagulants (DOACs) after a serious bleeding event in patients with atrial fibrillation ...

In 2020, the NHS became the world’s first health service to commit to net zero emissions. This includes the NHS’s large and ...

Background The elimination of HBV covalently closed circular DNA (cccDNA) remains a critical hurdle for chronic hepatitis B (CHB) management. Objective In this investigation, we examined the efficacy ...

Introduction The past decade has witnessed significant advancements in genome-targeted oncology drugs within the realm of precision medicine (PM). However, the cost-effectiveness of oncology PM in a ...